Lastly, our work demonstrates the role of miR-34a in maintaining tumor immunity, as administration of LNA-miR-34a-5p mimic resulted in a decrease in the percentage of PDL1+TAMs, which are reported to have pro-tumorigenic and immunosuppressive activity [51, 52]. The gene discussed is CD274; the disease is neoplasm.